Omeros Corporation (Nasdaq: OMER) ("Omeros" or the "Company") announced that on July 24, 2025 it entered into a securities ...

According to DelveInsight's analysis, the intermediate AMD market size is anticipated to grow with a significant CAGR during ...

Amgen has reported positive phase 3 results with its biosimilar version of AstraZeneca/Alexion's blockbuster rare disease drug Soliris, setting up a regulatory filing with the FDA. The biotech has ...

Alexion has routinely featured among lists of top biopharma takeover prospects in the last couple of years, and that was a good call – AstraZeneca has just swooped in with $39 billion cash-and ...

In November, China approved the first rare disease therapy from AstraZeneca, bringing innovative treatment options to paroxysmal nocturnal hemoglobinuria and atypical hemolytic-uremic syndrome, two ...

Signs of a blood clot in your arm (DVT) include swelling, pain, and discoloration. With emergency treatment, you can prevent life-threatening complications.

Polycythemia vera is a rare blood disorder that can cause complications, including blood clots and bleeding. Treatment can improve survival.